Good Morning! Nice to hear that Leronlimab was given to

New Post Public Reply Private Reply Replies (4) Message Board
Respert24
891
Good Morning!

Nice to hear that Leronlimab was given to the former president of the Philippines. Of course the only article out on the Manilla Times discussing his recovery notes that he was given Remdesivir. Which I'm sure he was. And which I'm sure did nothing. Then he gets Leronlimab and begins to recover. At least, that's what we all hope the timeline looks like. Common sense says it happened that way. Hard to tell though without some additional color surrounding his treatment.

I think we're likely to get that color as he gets further out of the weeds and coverage updates lead to interviews.

What I don't expect, and you shouldn't either, is a Monday morning PR about it from Cytodyn.

They likely will, and should in my opinion, follow the lead of the ex president and the government of the Philippines on this. Medical history and medical appointments are supposed to be confidential, and though public officials are often not afforded that luxury I'm positive the play here is to lay back behind the scenes and leverage this information into a bulk order and EUA. Let the former president and/or the current regime speak about it first. Let this puppy grow organically, which can lead to far more eyes on us than a PR from us would bring on Monday.

Don't get me wrong. I'd love to see one and I'd hope that it would actually break through to major media. I just don't think it will happen and I also think it probably shouldn't happen. At least just yet.

I also saw that someone (swordman?) showed that his Wikipedia page was updated to include Leronlimab. Which is hilarious because it couldn't have been any more obvious that it was done by a board member unless they'd thrown a #TechnicalAnalysis at the end Respert-style.

"His son also confirmed that Estrada was treated with Leronlimab, an experimental monoclonal antibody produced by the American company Cytodyn. This drug has had statistically significant results based on P value < .05 in reducing deaths in critically ill patients by 80+% at day 14 of a double-blind trial called CD12. Leronlimab has not yet received FDA approval or emergency use authorization in the United States or the Philippines.

#TechnicalAnalysis #NoButtStuff"


Good on ya, whoever you are. Well done.

But just for those unaware, Wikipedia is basically crowd-sourced. Just about anyone can update a page. So while it's great that it's on there I don't think it necessarily validates anything and it almost certainly shouldn't be construed as "major media picking up the story".

But, BUT, as people are searching for news on this recovery it could come in handy that there's a blurb about Leronlimab there. Many, many people go to Wikipedia to learn about things. It's a net positive.

The timelines are merging together and that's a good thing. The ex president gets Leronlimab either right around or just after the company announces that more doses are on their way for compassionate use. The same PR tells us that Cytodyn is currently negotiating the potential delivery of 100,000 vials for their compassionate use program. Covid is surging there right now and the current president is rumored to also potentially be sick as he's called off public engagements for the past 10 days or so. The Manilla Times had a story showing pictures of him out at night going for a walk to try to play down the potential that he's sick like much of the rest of his cabinet.

Taken all together, this truly could be a very fast and very furious move onto the world stage for Cytodyn. It's a long time coming, and well overdue. So while I'm excited about Hungary and Canada in the short term, I'm now most interested in how this plays out in the Philippines.

And by the way, I've been a shareholder for over two years so I know a little something about absurd and unexpected CYDY happenings. If this fucking story ends up coming around with the son having to admit he misread the name of the medication and that it was actually Lenzilumab that his dad got I'm going to break my computer in half.

And you'll want to too. But if that were to happen the most important thing is that you remember that you heard it here first. From the ScoopDaddy himself.

Sincerely,

ScoopDaddy24
#TechnicalAnalysis

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Parents Champion Meta's Online Safety Agreement

Updated Category News Views 5

Any old-timer in the market game will tell you this: safeguarding the next generation runs deeper than just chasing profits. A recent poll by the Coalition to Empower our Future reveals something that ain’t too surprising if you’ve been paying attention. Parents all over the nation are nodding along to Meta’s new move to bolster online protections for younger folks....

Continue Reading
Freeport-McMoRan Hit with Legal Probe: What's Next?

Updated Category News Views 4

Investigating the Movers and Shakers at Freeport When legal hawks like Kahn Swick & Foti, LLC sink their teeth into something, you can bet it's not just to nibble. These folks have jumped headfirst into probing Freeport-McMoRan Inc. (NYSE:FCX), ready to dismantle any smoke screens that might have been thrown up after the unfortunate Grasberg Block Cave mine incident. The...

Continue Reading
AEON's AI-Powered Agentic Checkout: A Game Changer?

Updated Category News Views 5

Cracking the Future: AEON Introduces Agentic Checkout There's a new sheriff in the AI economy: AEON, throwing its hat in the ring with the debut of Agentic Checkout. Now if you think we're just talking about basic automation here, think again. This thing's got its own AI Card that transforms your shopping commands into planned purchases. Think of it as handing over your...

Continue Reading
Actinium Pharma Unveils Plans at Key Investor Conference

Updated Category News Views 2

Actinium Pharmaceuticals Steps into the Spotlight Alright, folks, here we have Actinium Pharmaceuticals, Inc. gearing up to make some noise at the H.C. Wainwright 28th Annual Global Investment Conference. This isn't just any roadshow—it's a chance to showcase the kind of pioneering work they're doing in targeted radiotherapies. With Sandesh Seth, the Chairman, taking...

Continue Reading
2026 AI Talent Study Reveals Growth and Gaps

Updated Category News Views 2

Pushing Forward Yet Stumbling on the Details We've got a fresh scoop from the AI Leaders Council: They just rolled out their 2026 Corporate AI Talent Study. What's the big fuss? Well, they're tracking how companies are cozying up to artificial intelligence. Let's just say it's a mixed bag this time around. While almost everyone jumped on the AI bandwagon, only a scant 3%...

Continue Reading
Testing Grounds: Navigating PRN Test Insights

Updated Category News Views 0

Deciphering the PRN Tester Repetition Today we're staring at what feels like déjà vu—a simple PR test peppered with the classic sentence about a fox and a dog. It's like someone left the 'repeat' function stuck on during a slow day at the office. But hey, let’s dig in. Is there something more behind this repetitive text, or are we grumbling at a wall? Unpacking the...

Continue Reading
Pathlock Faces Identity Governance Opportunities in 2026

Updated Category News Views 3

Challenges in Identity Governance Emerge for 2026 Imagine a world where digital identities run wild—unmonitored, orphaned, dormant. Welcome to 2026, where identity governance and administration (IGA) face a reckoning, dragging enterprises into the spotlight as they scramble to protect against identity chaos. With Pathlock’s recent recognition in the Gartner Market...

Continue Reading
Agroz: Awards Fuel Momentum in AgriTech Sphere

Updated Category News Views 3

Agroz Surging Ahead with Global Acclaim There's a new breeze blowing through the AgTech industry, and it's carrying Agroz Inc. (NASDAQ: AGRZ) straight to the top. Fresh off the back of snagging several prestigious international awards, this vertically integrated agricultural tech powerhouse is making waves not just in Malaysia, but on the global stage. Top of the FoodTech...

Continue Reading
Kansas City's Haunts Condense Season to 13 Nights

Updated Category News Views 2

A Scary Short Season Takes Center Stage Hold onto your ghost hats, folks! The Kansas City haunt legends are shaking things up with a shorter scare season. This October, the infamous Edge of Hell and The Beast attractions are packing in the frights over just 13 nights, shifting their schedule due to rising September temperatures. Now, ain't that something? For their 52nd...

Continue Reading
AEVEX Faces $100K+ Losses in New Investor Lawsuit

Updated Category News Views 1

When the suits start flying, folks, you know there's a mess brewing somewhere in the market. Here we are, talking about AEVEX Corp, ticker NYSE:AVEX, and they’re facing some serious heat. There's some scuttlebutt about a class action lawsuit that’s got investors clutching onto their wallets tighter than ever. If you’ve been scouring over the papers, this lawsuit is...

Continue Reading

Top 5 Most Recently Viewed Articles

Liongard Welcomes David Powell as Chief Revenue Officer

Updated Category News Views 271

Liongard Welcomes David Powell as Chief Revenue Officer In an exciting development for the technology sector, Liongard has officially appointed David Powell as their new Chief Revenue Officer. This strategic move comes as Liongard aims to enhance its global reach in the Attack Surface Management landscape, particularly for Managed Service Providers (MSPs) and IT Service...

Continue Reading
Procurant LLC's Strategic Acquisition by GrubMarket Highlights Growth

Updated Category News Views 152

Procurant LLC's Acquisition by GrubMarket In an exciting development for the perishables industry, Procurant LLC, a cutting-edge, cloud-native SaaS platform, has been acquired by GrubMarket, Inc. This acquisition is a significant milestone for both companies, allowing them to merge their innovative technologies and enhance operational efficiencies within the perishables...

Continue Reading
Wuliangye's Global Greetings at New York's Times Square Celebration

Updated Category News Views 120

A Historic Celebration from Wuliangye Recently, Wuliangye, one of China's premier baijiu manufacturers, reached out to the global audience by showcasing its festive spirit. At the vibrant Times Square, a dazzling 3D advertisement captured the attention of passersby, celebrating the joy of the Spring Festival with a message of peace and harmony. The Essence of Spring...

Continue Reading
KuCoin Achieves New Milestone with Proof of Reserves Audit

Updated Category News Views 184

KuCoin Completes Independent Audit of Proof of Reserves Achieves the 32nd Consecutive Month of Publishing PoR Reports, Sustaining over 100% Coverage KuCoin, a leading global cryptocurrency exchange, proudly announces the successful completion of its most recent Proof of Reserves (PoR) audit, carried out by distinguished blockchain security firm Hacken. This audit marks...

Continue Reading
Cox Automotive Sees New Vehicle Sales Trend Shift in 2025

Updated Category News Views 574

Cox Automotive Insight on New Vehicle Sales Cox Automotive has released a forecast indicating that the new-vehicle sales pace for June is projected to settle around 15.3 million units. This is a slight increase from last year's June rate of 15.0 million, but represents a decrease from the previous month's figure of 15.6 million. This indicates a cooling market as...

Continue Reading